Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Nejat Altintas (Samsun, Turkey), Murat Aydin, Nejat Altintas, Levent Mutlu, Bulent Bilir, Musatfa Oran, Feti Tukubas, Birol Topcu. Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with COPD. Eur Respir J 2015; 46: Suppl. 59, 4003

Member's Comments

No comment yet.

Related content which might interest you: Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 The cycle of the nitric oxide metabolism in patients with COPD and chronic cerebrovascular diseases (CCVD) Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013 Temporal stability of feno measurement in COPD Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD Source: Eur Respir J 2010; 35: 72-78 Year: 2010 Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma Source: Eur Respir J 2006; 27: 951-956 Year: 2006 Fractional exhaled nitric oxide in chronic obstructive pulmonary disease Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Characterization of airway inflammation in patients with asthma COPD overlap syndrome using FeNO levels Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Source: Eur Respir J 2008; 32: 344-349 Year: 2008 Cytokine status and nitrosative stress indicators in patients with an exacerbation of COPD Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Weak association between exhaled nitric oxide and bronchial responsiveness in asthmatic patients Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Stability of exhaled nitric oxide (FENO) in patients with severe, steroid-dependent asthma Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008 Airway and systemic nitric oxide pathway in COPD Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Features of production nitric oxide at patients with a bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006 Exhaled nitric oxide predicts response to treatment in COPD patients with exacerbation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Changes in nitric oxide production in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 190s Year: 2006 Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma Source: Eur Respir J 2010; 35: 1221-1227 Year: 2010 Early and late effect of acute bronchodilation on exhaled nitric oxide in asthma Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Relation of asthma control and exhaled nitric oxide in patients with bronchial hyperresponsiveness to methacholine Source: Annual Congress 2013 –New issues in lung function testing Year: 2013